Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05468931 · ClinicalTrials.gov registry record · NA
Prostate Stimulation for Sexual Dysfunction
A NA study of Erectile Dysfunction and Sexual Dysfunction, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT05468931: Recruiting NA study of Erectile Dysfunction and Sexual Dysfunction, sponsored by Stanford University.
NCT05468931 is a NA study of Erectile Dysfunction and Sexual Dysfunction that is actively recruiting participants, run by Stanford University. The registered enrollment target is 15 participants, below the 231-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05468931, a NA study of Erectile Dysfunction and Sexual Dysfunction, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to use a device to stimulate the prostate with a goal of helping improve symptoms in men with sexual dysfunction.
Primary Outcome
score 0 to 30 with higher score meaning better erectile function
Conditions Studied
Interventions
- DEVICE Prostate stimulator
Study Locations (1)
California
- Stanford Healthcare, Stanford Hospital - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2024-04-18 |
| Est. Completion | 2026-06-01 |
| Phase | NA |
What NCT05468931 shows while recruiting
NCT05468931 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 231-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (94% lower).
The record links to 4 conditions, with Erectile Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which Prostate stimulator is the first listed.
NCT05468931 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05468931 about?
NCT05468931 is a clinical study titled "Prostate Stimulation for Sexual Dysfunction". The purpose of this study is to use a device to stimulate the prostate with a goal of helping improve symptoms in men with sexual dysfunction.
What is the current status of trial NCT05468931?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2024-04-18. Estimated completion is 2026-06-01.
What conditions does trial NCT05468931 study?
This clinical trial studies the following conditions: Erectile Dysfunction, Sexual Dysfunction, Delayed Ejaculation, Anorgasmia.
What interventions are being tested in trial NCT05468931?
The interventions under investigation include: Prostate stimulator (DEVICE).
Who is sponsoring clinical trial NCT05468931?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05468931 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Erectile Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05468931's enrollment target sits among peer trials
15 26th of 33 higher than 7 of 33 other Erectile Dysfunction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Erectile Dysfunction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease
RECRUITING · NA
-
Double-S: a Wearable Device for Erectile Dysfunction
RECRUITING · NA
-
Safety and Efficacy of the VERTICA® RF Device for the Treatment of ED
RECRUITING · NA
-
The Impact of Dietary Pattern on Erectile Function
RECRUITING · NA
-
Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain
RECRUITING · NA
-
The Impact of a Plant-based Meat Meal Versus an Animal Meat Meal on Erectile Function in Healthy Men.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI